BR100 Decreased By (-0.16%)
BR30 Decreased By (-0.26%)
KSE100 Decreased By (-0.21%)
KSE30 Decreased By (-0.28%)
AGHA 6.56 Increased By ▲ 0.04 (0.61%)
BECO 4.27 Decreased By ▼ -0.05 (-1.16%)
BML 57.51 Increased By ▲ 0.47 (0.82%)
BOP 29.08 Decreased By ▼ -0.17 (-0.58%)
CNERGY 12.52 Increased By ▲ 0.13 (1.05%)
CSIL 5.11 Decreased By ▼ -0.03 (-0.58%)
FCCL 52.12 Increased By ▲ 0.05 (0.1%)
FFL 14.03 Increased By ▲ 0.02 (0.14%)
FNEL 1.14 Decreased By ▼ -0.02 (-1.72%)
KEL 6.05 Increased By ▲ 0.09 (1.51%)
KOSM 5.38 No Change ▼ 0.00 (0%)
LOTCHEM 26.38 Decreased By ▼ -0.22 (-0.83%)
MLCF 90.63 Decreased By ▼ -0.32 (-0.35%)
NBP 158.42 Decreased By ▼ -2.32 (-1.44%)
NCPL 50.97 Decreased By ▼ -0.26 (-0.51%)
NPL 54.98 Decreased By ▼ -1.01 (-1.8%)
OGDC 306.12 Decreased By ▼ -2.54 (-0.82%)
PACE 9.78 Increased By ▲ 0.21 (2.19%)
PAEL 33.96 Increased By ▲ 0.23 (0.68%)
PIBTL 13.52 Decreased By ▼ -0.06 (-0.44%)
PPL 218.94 Increased By ▲ 0.59 (0.27%)
PRL 93.07 Increased By ▲ 1.95 (2.14%)
PTC 58.84 Decreased By ▼ -1.25 (-2.08%)
SSGC 23.06 Increased By ▲ 0.02 (0.09%)
TBL 9.33 Increased By ▲ 0.37 (4.13%)
TELE 7.17 No Change ▼ 0.00 (0%)
TPL 20.17 Increased By ▲ 0.76 (3.92%)
TPLP 12.38 Increased By ▲ 0.58 (4.92%)
TREET 23.72 Increased By ▲ 1.47 (6.61%)
TRG 55.29 Increased By ▲ 0.07 (0.13%)
Markets

European shares slip as banks slide on Trump’s credit card fee cap plan

  • The pan-European STOXX 600 slipped 0.2%
Published Updated
By

European shares dipped on Monday as tensions between the U.S. administration and Federal Reserve Chair Jerome Powell turned global markets cautious, and President Donald Trump’s call for a one-year cap on credit card interest rates weighed on banks.

The pan-European STOXX 600 slipped 0.2% by 0807 GMT.

Banks were the biggest drag on the index, dropping 1.1%.

Barclays fell 4.5%, hitting its lowest in nearly a month, and HSBC dropped about 1%.

On Friday, Trump called for a one-year cap on credit card interest rates at 10%, starting on January 20, but did not provide details.

Investors also fled to safe-haven assets after Trump’s officials threatened to indict Powell over comments to Congress about a building renovation project.

Powell said it was an attempt to influence interest rates.

Meanwhile, AstraZeneca dropped nearly 1% after losing its spot in the Nasdaq-100 index.

French biotech Abivax surged 22.8%. In an interview with Bloomberg News, Abivax CEO Marc de Garidel said major pharmaceutical companies cannot ignore the potential of his company’s experimental inflammatory bowel disease drug.

Comments

Comments are closed for this article.